Mobile

Clinical phase 2 study to investigate the safety and efficacy of Blinatumomab in adult subjects with newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) after treatment with standard of ca...

Update Il y a 4 ans
Reference: EUCTR2016-002190-35

Clinical phase 2 study to investigate the safety and efficacy of Blinatumomab in adult subjects with newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) after treatment with standard of care R-Chemotherapy. Estudio clínico de fase II que investiga la seguridad y la eficacia de blinatumomab en pacientes adultos con diagnóstico reciente de linfoma B difuso de células grandes (DLBCL) de alto riesgo después de quimioterapia-R de primera línea

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the safety of blinatumomab administered after frontline R-chemotherapy in newly diagnosed subjects with high-risk DLBCL. evaluar la seguridad de blinatumomab administrado después de quimioterapia-R de primera línea en sujetos con diagnóstico reciente de DLBCL de alto riesgo.

Inclusion criteria

  • high-risk diffuse large B-cell lymphoma (DLBCL ),linfoma B difuso de células grandes (DLBCL) de alto riesgo

Links